SHAIK, MOHAMMED MONSOOR
 Distribuzione geografica
Continente #
EU - Europa 2.957
AS - Asia 1.401
NA - Nord America 1.098
SA - Sud America 194
AF - Africa 40
OC - Oceania 3
Totale 5.693
Nazione #
SE - Svezia 1.869
US - Stati Uniti d'America 1.051
IT - Italia 595
SG - Singapore 422
CN - Cina 279
VN - Vietnam 198
HK - Hong Kong 175
BR - Brasile 140
RU - Federazione Russa 131
IN - India 67
GB - Regno Unito 60
BD - Bangladesh 56
FR - Francia 56
DE - Germania 41
KR - Corea 41
NL - Olanda 37
ES - Italia 27
JP - Giappone 27
FI - Finlandia 26
IE - Irlanda 26
PL - Polonia 26
ID - Indonesia 23
CA - Canada 22
TR - Turchia 20
AR - Argentina 19
PK - Pakistan 16
DK - Danimarca 15
IQ - Iraq 14
ZA - Sudafrica 14
MX - Messico 13
CL - Cile 10
BE - Belgio 9
AT - Austria 8
MA - Marocco 8
SA - Arabia Saudita 8
UA - Ucraina 8
CO - Colombia 7
EC - Ecuador 7
MY - Malesia 7
PH - Filippine 7
UZ - Uzbekistan 7
IL - Israele 6
VE - Venezuela 6
LB - Libano 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PT - Portogallo 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
JO - Giordania 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 5.693
Città #
Stockholm 1.866
Singapore 271
Milan 222
San Jose 170
Hong Kong 164
Ashburn 145
Ho Chi Minh City 68
Los Angeles 68
Hefei 64
Hanoi 56
Santa Clara 54
New York 42
Seoul 38
Beijing 34
Council Bluffs 34
Dallas 33
Chicago 29
Rome 29
Buffalo 27
Dublin 27
Tokyo 26
São Paulo 25
Helsinki 20
Boardman 19
Frankfurt am Main 18
Jakarta 18
Shanghai 18
Warsaw 18
Amsterdam 16
Bologna 15
Florence 14
Hyderabad 14
Maastricht 14
Paris 14
Chennai 13
The Dalles 13
Orem 12
Turin 12
Washington 12
Copenhagen 11
Lauterbourg 11
Sassuolo 11
Johannesburg 10
London 10
Brescia 9
Denver 9
Houston 9
Naples 9
Atlanta 8
Desio 8
Nuremberg 8
Philadelphia 8
Barnet 7
Boston 7
Brooklyn 7
Haiphong 7
Hangzhou 7
Montreal 7
Poplar 7
Rometta 7
Sorbolo 7
Tashkent 7
Toronto 7
Baghdad 6
Dhaka 6
Istanbul 6
Moscow 6
Phoenix 6
Santiago 6
Columbus 5
Da Nang 5
Guangzhou 5
Kent 5
Krakow 5
Kuala Lumpur 5
Lappeenranta 5
Mumbai 5
New Delhi 5
Pisogne 5
Reading 5
San Giuliano Terme 5
Vienna 5
Berlin 4
Bexley 4
Charlotte 4
City of London 4
Como 4
Edinburgh 4
Heverlee 4
Inzago 4
Medellín 4
Mexico City 4
Monza 4
Munich 4
Nairobi 4
Pasadena 4
Saint-Martin-d'Hères 4
Salò 4
San Francisco 4
Sarnico 4
Totale 4.123
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.955
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 398
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 294
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 287
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 274
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 271
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 260
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 244
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 224
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 223
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection 200
Self-Activated Fluorescent Hydroxyapatite Nanoparticles: A Promising Agent for Bioimaging and Biolabeling 172
Ellagic acid containing collagen-chitosan scaffolds as potential antioxidative bio-materials for tissue engineering applications 155
Antioxidant-antibacterial containing bi-layer scaffolds as potential candidates for management of oxidative stress and infections in wound healing 155
Novel melt-down neutralization method for synthesis of chitosan-silver scaffolds for tissue engineering applications 143
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 132
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants 70
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS 56
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants 54
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators 47
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 44
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 42
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 40
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 36
Totale 5.776
Categoria #
all - tutte 13.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202330 0 0 0 0 0 0 0 0 0 18 7 5
2023/2024226 1 7 48 18 12 23 27 2 22 18 17 31
2024/2025989 29 66 95 62 68 52 60 33 77 149 85 213
2025/20264.474 229 141 153 285 234 110 332 129 273 2.200 120 268
2026/202757 57 0 0 0 0 0 0 0 0 0 0 0
Totale 5.776